Download presentation
Presentation is loading. Please wait.
Published byMarlene Powers Modified over 5 years ago
1
Dopaminergic agents Medicinal Chemistry 2018-2019 4th Year
Drugs Acting On CNS Dopaminergic agents Medicinal Chemistry th Year Mohammed N. Sabir College of Pharmacy-UOS
2
Your reference… Chapters 12 & 13
3
Introduction… The majority of CNS drugs act on specific receptors that modulate synaptic transmission, however; anesthetics and alcohol exhibit non-specific action.
4
Introduction… Their are two types of channels:-
Their are two types of channels:- Voltage-gated ion channels Ligand gated (ionotropic receptors)
5
Introduction… Dopamine (DA) is a CNS NT controlling emotion, movement and reward mechanisms and is metabolic precursor for EN and NE.
6
Introduction… DA production from L-Tyrosine
7
Introduction… DA storage & release… D2 DAT D1
8
Introduction… Modulation of DA release and DA receptors…
9
Introduction… D1 receptors family D2 receptors family
10
D1 & D2-receptors DA superimposition on D1/D2 receptors domain…
11
Introduction… Postsynaptic DA receptors and subtypes, (GABA)ergic, Glutaminergic and Cholinergic.
12
Introduction… DA transporter (deactivator)
13
Dopaminergic pathways in brain…
Nigrostriatal Mesocortical Mesolimbic Tuberohypophyseal
14
Introduction… Parkinson Disease (PD) and DA neurons.
15
Introduction… DA metabolism - MAO - COMT
16
Introduction… HVA & DOPAC
17
Introduction… DA pathways in brain Nigrastriatal Mesocortical
Mesolimbic Tuberohypophyseal
18
Parkinson disease (PD)
19
Antiparkinson agents…
PD & L-Dopa/Carbidopa
20
SAR & metabolism of L-Dopa and Carbidopa
21
Selective MAO-Is… MAO-Is - Selegiline - Rasagiline
22
MAO-I SAR & Metabolism
23
DA agonists… Ergot derivatives Pergolide Cabergolide Bromocriptine
24
DA agonists… SAR & Metabolism
25
DA agonists… Nonergot derivatives Apomorphine Pramipexole Rapinirole
Rotigotine
26
DA agonists… SAR & Metabolism
27
DA agonists… COMT-Inhibitors Tolcapon Entacapone
28
DA agonists… SAR & Metabolism
29
Antipsychotic agents…
Disease state and causes DA hypothesis of Schizophrenia (DHS) D1, D2 receptors, DA, Glutamate and serotonin
30
Antipsychotic agents…
1st generation antipsychotics… 1-Phenothiazenes 2-Thioxanthenes 3-Butyrophenones 4-Dihydroindolones (Molindone)
31
1st generation antipsychotics…
Phenothiazenes
32
1st generation antipsychotics…
Phenothiazenes
33
1st generation antipsychotics…
Phenothiazenes SAR…
34
1st generation antipsychotics…
Thioxanthenes
35
1st generation antipsychotics…
Thioxanthenes Thioxanthene Chlorprothixene
36
1st generation antipsychotics…
Thioxanthenes SAR & Metabolism
37
1st generation antipsychotics…
Phase I reaction Oxidative N-demethyhlation Aromatic hydroxylation Tertiary amine oxidation of the side chain Oxidative deamination N-10 Alkylation
38
1st generation antipsychotics…
Butyrophenones and related agents - Haloperidol - Droperidol - Pimozide
39
1st generation antipsychotics…
Haloperidol
40
1st generation antipsychotics…
Droperidol
41
1st generation antipsychotics…
Pimozide
42
1st generation antipsychotics…
Metabolism of butyrophenones 1st pass mechanism include:- N-dealkylation Reduction (ketone) Oxidation N-Oxidation
43
1st generation antipsychotics…
Haloperidol decanoate
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.